CTEPH News

January 11, 2019January 14, 2019

Long-term Adempas Treatment May Reverse Right Heart Deficits in Patients with PAH, CTEPH, Study Finds

CTEPH News, News, PAH News

Long-term treatment with Adempas (riociguat) can reduce right heart size and improve the heart’s pumping function in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), ... Read more

January 3, 2019January 11, 2019

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients

CTEPH News, News

Worse measures of blood flow, arterial oxygenation, and cardiac function may underlie the poor clinical condition of chronic thromboembolic pulmonary hypertension (CTEPH) patients who also have obstructive sleep apnea ... Read more

December 6, 2018December 7, 2018

CTEPH Software Receives FDA’s Breakthrough Device Designation

CTEPH News

The U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to software being developed by Bayer and Merck — known as MSD outside the U.S. and Canada — to ... Read more

October 22, 2018October 23, 2018

New Procedure Successfully Treats CTEPH Patient at Northwestern Hospital in Illinois

CTEPH News, News

A new procedure, performed at Northwestern Memorial Hospital in Illinois, successfully treated a patient with pulmonary hypertension (PH) caused by blood clots formed in the lung vessels, a condition referred ... Read more

October 3, 2018October 15, 2018

Inspiratory Muscle Weakness Aggravates Shortness of Breath in CTEPH Patients, Study Shows

CTEPH News, News

Inspiratory muscle weakness aggravates shortness of breath caused by exertion and lung function capacity in patients with chronic thromboembolic pulmonary hypertension, a study has found. The study, “Inspiratory muscle weakness ... Read more

September 5, 2018September 6, 2018

Actelion Seeks Expanded Approval of Opsumit for Treatment of CTEPH in Europe

CTEPH News, News

Actelion Pharmaceuticals has filed a request with the European Medicines Agency for the expanded approval of Opsumit (macitentan) as a treatment for adults with moderate to severe inoperable chronic ... Read more

August 3, 2018August 8, 2018

Heart Arrhythmias Decrease Survival in PAH and CTEPH Patients, Study Suggests

CTEPH News, News, PAH News

Estimated survival in patients with either pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) is worse if they also have atrial arrhythmias, according to a new U.S. study. ... Read more

July 23, 2018July 25, 2018

Adempas Therapy Improves Blood Flow in Sildenafil-treated CTEPH Patients, Study Says

CTEPH News, News

Adempas therapy significantly improves lung and heart function in patients with chronic thromboembolic pulmonary hypertension (CTEPH) previously treated off-label with sildenafil, according to a Polish study. The study reporting ... Read more

July 19, 2018July 19, 2018

Bayer Launches ‘MyMentor’ Program, Connecting PAH or CTEPH Patients to Others with Firsthand Experience

CTEPH News, News, PAH News

Patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) and their caregivers can now access myMentor, a U.S. support program established by Bayer. The company launched the program ... Read more

June 28, 2018June 28, 2018

Surgical Removal of Blood Clots Reverses PH But Not Sleep Issues in CTEPH Patients, Study Finds

CTEPH News, News

Surgery to remove blood clots from the arteries improves pulmonary hypertension (PH) symptoms but not underlying sleep disorders in patients with chronic thromboembolic pulmonary hypertension (CTEPH), according to a ... Read more

Pin It on Pinterest